Gastrointestinal Radiofrequency Ablation Systems Market Outlook:
Gastrointestinal Radiofrequency Ablation Systems Market size was over USD 4.54 billion in 2025 and is poised to exceed USD 9.01 billion by 2035, growing at over 7.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of gastrointestinal radiofrequency ablation systems is evaluated at USD 4.83 billion.
The growth of the market can be attributed to the growing incidence of cancer cases globally. RFA systems may become more popular as cancer rates rise since medical professionals are looking for less invasive ways to treat their patients. Globally over 6 million new instances of cancer will be reported among persons 80 years of age or older in 2050 which is more than 20% of all cancer cases.
In addition to these, factors that are believed to fuel the market growth of gastrointestinal radiofrequency ablation systems include the rise in technological advancements. For instance, RFA technology developments have resulted in the creation of more accurate and effective devices that can provide targeted energy to the damaged tissue with the least amount of harm to healthy tissue nearby. As a result, the method is now safer and more efficient, which may be causing RFA system demand to rise.
